BR112018069392A2 - suspensão coloidal de nanocápsulas, nanocápsulas, micropartículas, método para o fabricação de uma suspensão coloidal, método para o fabricação de nanocápsulas e uso de nanocápsulas - Google Patents

suspensão coloidal de nanocápsulas, nanocápsulas, micropartículas, método para o fabricação de uma suspensão coloidal, método para o fabricação de nanocápsulas e uso de nanocápsulas

Info

Publication number
BR112018069392A2
BR112018069392A2 BR112018069392A BR112018069392A BR112018069392A2 BR 112018069392 A2 BR112018069392 A2 BR 112018069392A2 BR 112018069392 A BR112018069392 A BR 112018069392A BR 112018069392 A BR112018069392 A BR 112018069392A BR 112018069392 A2 BR112018069392 A2 BR 112018069392A2
Authority
BR
Brazil
Prior art keywords
nanocapsules
manufacturing
colloidal suspension
microparticles
colloidal
Prior art date
Application number
BR112018069392A
Other languages
English (en)
Other versions
BR112018069392B1 (pt
Inventor
Preveraud Damien
Rosilio Véronique
Original Assignee
Adisseo France Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adisseo France Sas filed Critical Adisseo France Sas
Publication of BR112018069392A2 publication Critical patent/BR112018069392A2/pt
Publication of BR112018069392B1 publication Critical patent/BR112018069392B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Colloid Chemistry (AREA)
  • Fodder In General (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

a invenção refere-se a nanocápsulas na forma de uma suspensão coloidal ou na forma seca, as referidas nanocápsulas compreendendo pelo menos um ingrediente ativo na forma de um óleo, um tensoativo iônico, opcionalmente um tensoativo não iônico, e um polímero hidrofílico. a invenção também diz respeito à sua fabricação e seus usos.
BR112018069392-8A 2016-03-25 2017-03-17 Suspensão coloidal de nanocápsulas, nanocápsulas, micropartículas e usos de nanocápsulas BR112018069392B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1652592 2016-03-25
FR16/52592 2016-03-25
PCT/FR2017/050622 WO2017162963A1 (fr) 2016-03-25 2017-03-17 Nanocapsules de principe actif liposoluble, fabrication et utilisations

Publications (2)

Publication Number Publication Date
BR112018069392A2 true BR112018069392A2 (pt) 2019-01-22
BR112018069392B1 BR112018069392B1 (pt) 2022-11-22

Family

ID=56263861

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018069392-8A BR112018069392B1 (pt) 2016-03-25 2017-03-17 Suspensão coloidal de nanocápsulas, nanocápsulas, micropartículas e usos de nanocápsulas

Country Status (13)

Country Link
US (1) US10765639B2 (pt)
EP (1) EP3432729A1 (pt)
JP (1) JP2019513359A (pt)
KR (1) KR20180128025A (pt)
CN (1) CN108882729A (pt)
AU (1) AU2017236312B2 (pt)
BR (1) BR112018069392B1 (pt)
CA (1) CA3017931C (pt)
MX (1) MX2018011620A (pt)
RU (1) RU2745844C2 (pt)
UA (1) UA127243C2 (pt)
WO (1) WO2017162963A1 (pt)
ZA (1) ZA201806197B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102370217B1 (ko) * 2019-11-27 2022-03-07 군산대학교 산학협력단 유자 오일을 포함하는 나노복합체의 제조방법
RU2736051C1 (ru) * 2020-03-04 2020-11-11 Александр Александрович Кролевец Способ получения нанокапсул сухого экстракта эхинацеи
RU2743010C1 (ru) * 2020-03-23 2021-02-12 Таисия Скандарбековна Гутнова Способ получения нанокапсул витамина D3
CN114847488A (zh) * 2022-05-17 2022-08-05 江南大学 一种高稳定性和生物可给率的橘味维生素a-维生素d纳米复合载体制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788007B1 (fr) * 1999-01-05 2001-02-09 Oreal Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
FR2803203B1 (fr) * 1999-12-31 2002-05-10 Fournier Ind & Sante Nouvelles formulations galeniques du fenofibrate
FR2806005B1 (fr) * 2000-03-10 2002-06-14 Univ Claude Bernard Lyon Procede de preparation de particules colloidales sous forme de nanocapsules
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
JP2005028559A (ja) * 2003-07-08 2005-02-03 Shinobu Ito ナノカプセル
FR2864900B1 (fr) * 2004-01-09 2007-10-12 Oreal Dispersion aqueuse de nanocapsules a coeur huileux
EP1937204B1 (en) * 2005-10-18 2018-07-25 Amorepacific Corporation Cationic polymer nanoparticles encapsulating an active ingredients, and the cosmetic composition containing the same
ATE515260T1 (de) * 2006-03-13 2011-07-15 Advanced In Vitro Cell Technologies S L Stabile nanokapselsysteme für die verabreichung von wirkstoffen
FR2924943A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition dermatologique comprenant des nanocapsules polymeriques de calcitriol, son procede de preparation et son utilisation
BRPI0805854A2 (pt) * 2008-10-10 2010-08-24 Biolab Sanus Farmaceutica Ltda sistema nanoparticulado, processo de preparaÇço do mesmo, uso do mesmo, composiÇço fotoproterora, processo de preparaÇço da mesma, mÉtodo de prevenÇço de doenÇas e distérbios da pele
BRPI1014276B8 (pt) * 2009-04-24 2021-05-25 Iceutica Pty Ltd produção de nanopartículas encapsuladas em escala comercial
EP2266546A1 (en) * 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Process for the preparation of colloidal systems for the delivery of active compounds
ES2351756B1 (es) * 2009-07-28 2011-10-05 Universidad Del Pais Vasco Nanopartículas lipídicas para terapia génica.
CA2843943A1 (en) * 2014-02-20 2014-05-28 Pankaj Modi Oral formulations of chemotherapeutic agents
RU2557900C1 (ru) * 2014-03-25 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул витаминов
WO2017021983A1 (en) * 2015-08-06 2017-02-09 Rubicon Research Private Limited Particulate delivery systems

Also Published As

Publication number Publication date
RU2018135575A (ru) 2020-04-27
WO2017162963A1 (fr) 2017-09-28
BR112018069392B1 (pt) 2022-11-22
UA127243C2 (uk) 2023-06-21
MX2018011620A (es) 2019-03-14
CN108882729A (zh) 2018-11-23
JP2019513359A (ja) 2019-05-30
CA3017931C (fr) 2024-01-09
US10765639B2 (en) 2020-09-08
RU2018135575A3 (pt) 2020-06-09
RU2745844C2 (ru) 2021-04-01
CA3017931A1 (fr) 2017-09-28
ZA201806197B (en) 2019-06-26
AU2017236312A1 (en) 2018-10-18
US20190083414A1 (en) 2019-03-21
KR20180128025A (ko) 2018-11-30
AU2017236312B2 (en) 2021-02-04
EP3432729A1 (fr) 2019-01-30

Similar Documents

Publication Publication Date Title
BR112018069392A2 (pt) suspensão coloidal de nanocápsulas, nanocápsulas, micropartículas, método para o fabricação de uma suspensão coloidal, método para o fabricação de nanocápsulas e uso de nanocápsulas
BR112018010673A2 (pt) moléculas de anticorpo para april e seus usos
BR112016028942A2 (pt) método para preparar uma composição estável com perfume
BR112018017172A2 (pt) anticorpos monoclonais anti-alfa-sinucleína para prevenção da agregação de tau
CO2017000416A2 (es) Una composición hidráulica
BR112016020454A2 (pt) anticorpos anti-c5 que têm farmacocinética melhorada
WO2016097370A3 (en) Anti-axl antagonistic antibodies
WO2016016841A3 (en) Disc brake caliper employing a spring to influence pads acting on the disc of the disc brake
BR112018011459A2 (pt) processo, material zeolítico, e, uso de um material zeolítico.
BR112019003987A2 (pt) formas sólidas de mesilato de cenicriviroc e processos de produção das formas sólidas de mesilato de cenicriviroc
BR112018016729A2 (pt) novo composto de tiofeno substituído nas posições 2,3,5, utilizado como inibidor de proteína quinase
CL2018001775A1 (es) Unidades de administración de agroquímicos de liberación controlada, su fabricación y uso
BR112017004393A2 (pt) formulações de anticorpo
AR100407A1 (es) Aplicaciones volátiles contra patógenos
PL3525799T3 (pl) Sposób ustanawiania, przywracania i utrzymywania homeostazy powierzchni oka
BR112017015512A2 (pt) componente elétrico tendo uma seção de sensor feita de concreto, método para sua produção e seu uso
NI201900096A (es) Moduladores de la expresión de pcsk9
BR112016017776A2 (pt) Formas sólidas de 2-(terc-butilamino)-4-((1r,3r,4r)-3-hidróxi-4-metil-ciclo-hexilamino)-pirimidina-5-carboxamida, composições das mesmas e métodos para seu uso
AR107177A1 (es) Indicaciones de características de tráfico para el control del establecimiento de conexiones
AR100607A1 (es) Un método para la modificación de una lipasa
MX2018012311A (es) Composicion oftalmica que comprende pvp-i.
BR112016017365A8 (pt) buquê de flores cortadas, uso de uma ou mais flores cortadas que pertencem ao gênero kalanchoe, método para conferir uma frescura prolongada a um meio nutriente aquoso para flores cortadas e longevidade prolongada a uma ou mais flores cortadas
BR112018005299A2 (pt) 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso
BR112019000878A2 (pt) absorvente interno.
EA201991112A1 (ru) Композиции и способы, связанные с пиридиноилпиперидиновыми агонистами 5-ht1f

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/03/2017, OBSERVADAS AS CONDICOES LEGAIS